| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP & Chief Financial Officer
3 companies
Mark G Foletta is Director at DXCM, with reported holdings spanning 3 companies. From April 2016 to August 2026, the filings on record show 3 open-market purchases and 28 sales. Mark G Foletta's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $6.0M at current prices.
Our model assigns Mark G Foletta a strong insider score of 70/100, based on 15 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +13.4%.
Mark G Foletta's largest disclosed position is in DXCM as Director, worth about $4.1M. The DXCM filings lean toward selling, a net 35,750 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | DXCM Dexcom Inc | Director | Sell | 500 | $562.83 | $281,415.78 | -3.8% | -25.5% | -13.9% | |
| Nov 1, 2021 | DXCM Dexcom Inc | Director | Sell | 500 | $626.32 | $313,161.58 | -3.7% | -31.4% | -24.1% | |
| Oct 1, 2021 | DXCM Dexcom Inc | Director | Sell | 500 | $543.09 | $271,546.70 | -3.5% | -1.6% | -41.4% | |
| Jun 11, 2021 | AMN Amn Healthcare Services Inc | Director | Sell | 2,500 | $95.02 | $237,540.00 | -16.9% | +18.4% | +4.7% | |
| Nov 16, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $341.32 | $341,319.53 | -7.0% | - | - | |
| Oct 15, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $396.82 | $396,819.42 | -6.6% | - | - | |
| Sep 14, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $394.14 | $394,135.55 | -6.2% | - | - | |
| Mar 3, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $277.08 | $277,079.31 | -7.1% | - | - | |
| Feb 3, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $237.84 | $237,842.98 | -6.6% | - | - | |
| Jan 3, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $218.05 | $218,052.89 | -6.2% | - | - |